Sprinklr Announces Fourth Quarter and Full Year Fiscal 2022 Results
Go back to Sprinklr Announces Fourth Quarter and Full Year Fiscal 2022 Results| Cardium Therapeutics, Inc. (NYSE: CXM) | Delayed: 4.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.97 | 52 Week High | $1.44 | |||
| Open | $4.97 | 52 Week Low | $0.06 | |||
| Day High | $4.97 | P/E | N/A | |||
| Day Low | $4.97 | EPS | $-1.24 | |||
| Volume | 7 | |||||
